RELATIONSHIP BETWEEN THE RESULTS OF IMMUNOHISTOCHEMICAL EXAMINATION (PHH3, KI-67) AND POSITRON EMISSION TOMOGRAPHY DATA (SUVMAX) OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA by Lysak Andrii & Diadyk Olena
 
 
 
Scholarly Publisher 
RS Global Sp. z O.O. 
ISNI: 0000 0004 8495 2390 
 
Dolna 17, Warsaw, Poland 00-773 
Tel: +48 226 0 227 03 
Email: editorial_office@rsglobal.pl 
 
 
 
JOURNAL World Science 
p-ISSN 2413-1032 
e-ISSN 2414-6404 
PUBLISHER RS Global Sp. z O.O., Poland 
  
ARTICLE TITLE 
RELATIONSHIP BETWEEN THE RESULTS OF 
IMMUNOHISTOCHEMICAL EXAMINATION (PHH3, 
KI-67) AND POSITRON EMISSION TOMOGRAPHY DATA 
(SUVMAX) OF OROPHARYNGEAL SQUAMOUS CELL 
CARCINOMA 
AUTHOR(S) Lysak Andrii, Diadyk Olena 
ARTICLE INFO 
Lysak Andrii, Diadyk Olena. (2020) Relationship Between the 
Results of Immunohistochemical Examination (pHH3, Ki-67) 
and Positron Emission Tomography Data (SUVmax) of 
Oropharyngeal Squamous Cell Carcinoma. World Science. 
7(59). doi: 10.31435/rsglobal_ws/30092020/7168 
DOI https://doi.org/10.31435/rsglobal_ws/30092020/7168 
RECEIVED 27 July 2020 
ACCEPTED 25 August 2020 
PUBLISHED 30 August 2020 
LICENSE 
 
This work is licensed under a Creative Commons Attribution 
4.0 International License. 
 
© The author(s) 2020. This publication is an open access article. 
  
World Science 7(59), 2020 
 
RS Global 1 
 
RELATIONSHIP BETWEEN THE RESULTS OF 
IMMUNOHISTOCHEMICAL EXAMINATION (PHH3, 
KI-67) AND POSITRON EMISSION TOMOGRAPHY 
DATA (SUVMAX) OF OROPHARYNGEAL SQUAMOUS 
CELL CARCINOMA 
 
Lysak Andrii, Graduate Student of the Department of Pathological and Topographic Anatomy, 
Shupyk National Medical Academy of Postgraduate Education, Pathoanatomical Center of the 
National Military Medical Clinical Centre of the Main Military Clinical Hospital, Kyiv, 
ORCID ID: https://orcid.org/0000-0003-0917-2688 
 
Diadyk Olena, Doctor of Medicine, Professor, Head of the Department of Pathological and 
Topographic Anatomy, Shupyk National Academy of Postgraduate Education, Kyiv 
 
DOI: https://doi.org/10.31435/rsglobal_ws/30092020/7168 
 
ARTICLE INFO 
Received: 27 July 2020 
Accepted: 25 August 2020 
Published: 30 August 2020 
 
ABSTRACT 
The authors established the relationship between the indicators of 
immunohistochemical examination — proliferation markers (Ki67) and 
mitotic count (pHH3) with the indicators of positron emission 
tomography — SUVmax. The identified patterns of cancer cells 
differentiation and their metabolic activity are promising for the 
diagnosing and screening of tumours of varying degrees of progression 
and origin, which will allow forecasting the course of the disease at all 
stages of diagnostics. The study intends to assess the level of 
oropharyngeal squamous cell histopathological differentiation by 
immunohistochemical diagnostic methods, and their metabolic activity 
using positron emission tomography. 
KEYWORDS 
oropharyngeal squamous cell 
carcinoma,  
tumour differentiation, metabolic 
activity, immunohistochemistry,  
positron emission tomography. 
1. Study of the activity of metabolic processes of transformed oropharyngeal cancer cells using positron 
emission tomography; 
2. Determination of tumour proliferative potential by the number of positive stains to Ki-67 (%) and pHH3 by 
immunohistochemical diagnostic methods; 
3. Identification of the relationship between morphological changes of oropharyngeal cancer cells and their 
metabolic activity. 
Materials and methods. We studied 130 samples of squamous cell carcinoma of the oropharyngeal area. We 
determined the level of metabolic activity — SUVmax — by positron emission tomography (PET) at the 
preoperative patient treatment stage. In the postoperative period, the proliferation index (Ki67) and the mitotic 
count (pHH3) were determined by histological and immunohistochemical methods. Upon assessment of the level 
of differentiation of tumour cells, patients were divided into three groups: Group I - patients having tumour cells 
in the G1 phase of mitosis (28 patients); Group II — tumour cells in the G2 phase of mitosis (48 patients); Group 
III — tumour cells in the G3 phase of mitosis (54 patients). We evaluated PET results according to the 
Maximum Standard Unit Value (SUVmax). 
We determined the relationship between morphological changes and metabolic activity of tumour cells by 2-
fluoro-[18F]-2-deoxy-D-glucose accumulation and immunohistochemical examination. 
Results. We established a statistically significant difference between the groups (p<0.001 according to the Kruskal-
Wallis test for all indicators). Thus, with decreasing Me level, the differentiation of SUVmax of tumours 
significantly (p<0.05) increases, which indicates an increase in the degree of malignancy of tumours. We evaluated 
the results of immunohistochemical examination by Ki67 and pH3 markers in the study groups. Comparing Ki67 
and pHH3, a statistically significant difference was found between the groups (p<0.001 according to the Kruskal-
Wallis test for all indicators). Thus, with a decrease in the Me level, the differentiation of Ki67 increases 
significantly (p<0.05), and an increase in pH3 indicates an increase in the degree of malignancy of tumours. 
Conclusions. We statistically proved the relationship between Ki67, pH3 and SUVmax in oropharyngeal 
squamous cell carcinoma. We established the possibility of preoperative forcasting of the level of tumour 
differentiation and the use of pHH3 immunohistochemical marker as a reliable criterion for assessing the level of 
tumour differentiation, including hardly diagnosable squamous cell carcinoma. 
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Introduction. Differentiation of tumour cells is a central aspect of histopathological 
classification of malignant neoplasms. The stages of differentiation are strongly related to the 
metabolic activity of the transformed cells and the tumour behaviour. It is known that undifferentiated 
tumour is more aggressive than its more differentiated analogue [1]. Tumour differentiation is directly 
related to the expression and function of genes that determine the metabolic activity and direction of 
development of transformed cells [2]. The mechanisms of differentiation of tumour cells, as well as 
the relationship of morphological changes in cells with their metabolic activity are poorly studied. 
Besides, the level of metabolic activity of transformed cells underlies the diagnosis and evaluation of 
the degree of tumour differentiation, which plays a huge role in the treatment of cancer patients [3]. 
Treatment of oropharyngeal tumours is a time-consuming and unresolved problem of modern 
oncology. Anatomical and functional features of this area are the tendency of malignant tumours of 
this localization to rapid infiltrative growth, while early metastasing to lymph nodes cause severe 
disease and create difficulties in diagnosing and treatment [4]. Diagnostics of oropharyngeal 
neoplasms includes two stages: preoperative and postoperative. Diagnostics in the preoperative period 
helps to establish the location and size of the tumour, without determining its degree of malignancy. 
Preoperative diagnostics of oropharyngeal tumours is performed using positron emission 
tomography (PET) and computed tomography (CT). These methods belong to non-invasive 
diagnostics — one of the priority areas of medical research [5, 6]. 
The immunohistochemical marker — Ki67 — is an important marker for the verification of 
malignant tumours, which is determined to establish the proliferation index of tumour cells. Ki67 
belongs to the nuclear antigens that are involved in the regulation of the cell cycle and are found in 
cell nuclei in G1-, S- and G2 phases of the cell cycle, as well as during the mitotic phase [7]. Ki67 as a 
monoclonal proliferation marker gives a positive reaction in G1A, G1B, S, G2 and M-phases of the 
cell cycle, but is not detected in G0, G1T, G1a, G1b phases. Nowadays, antibodies to Ki67 have 
become the standard for assessing the proliferative activity of transformed cells [8]. It is proved that 
the increase in the expression of this marker is directly proportional to the formation of the aggressive 
phenotype of many malignant tumours [9]. In particular, the high level of Ki67 expression is a 
prognostically unfavourable factor for breast, ovarian, prostate cancer, melanocytic tumours, 
gastrointestinal stromal tumours [8, 10, 11]. 
Phosphohistone H3 (pHH3) may be another proliferation marker. pHH3 is a histone protein 
that is part of DNA chromatin, and plays an important role in chromosome condensation and cell cycle 
progression during mitosis and meiosis after phosphorylation of serine-10 and serine-28 residues. 
Phosphorylation occurs during the late G2 phase before the onset of prophase, while 
dephosphorylation occurs slowly from late anaphase to early telophase. Therefore, in the metaphase 
histone H3 is always strongly phosphorylated, which is manifested by a positive test for pHH3, while 
in the interphase there is minimal or no expression of pHH3 — a property that allows pHH3 to be 
detected only in mitotically active cells [11]. For this reason, we hypothesized that pHH3 may be a 
better prognostic marker than the Ki67 marker and better detect tumour cell metastasis. 
The research objective is to assess the level of squamous cell histopathological 
differentiation of cells (Ki-67, pHH3) with oropharyngeal carcinoma by immunohistochemical 
diagnostic methods, and their metabolic activity using positron emission tomography (SUVmax). 
Materials and research methods. The study involved 130 patients with oropharyngeal 
squamous cell carcinoma. Among patients, men accounted for 75% (98 men), women - 25% (32 
women).  
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Diagnosis of the detected pathology was performed in the preoperative period using PET/CT 
examination using Philips Gemini PET/CT-System series C. The PET method determined the level of 
metabolic activity — SUVmax [12, 13]. 
In the postoperative period, pieces of transformed tissue were taken from the tumour for 
histological and immunohistochemical examinations. The fixation was performed in a 10% solution of 
neutral formalin. Proliferation index (Ki67) and mitotic count (pHH3) were determined by histological 
and immunohistochemical methods. 
In determining the degree of differentiation of tumour cells we used the classification of 
Anneroth et al. and Bryne et al. [14], presented in Table 1. 
 
Table 1. Evaluation of the level of differentiation of tumour cells 
Criterion 
Number of points 
1 2 3 4 
The level of keratinization 
(% of cells) 
>50  20 –50  5 – 20 0 – 5 
Polymorphism of nuclei 
(% of mature cells) 
> 75  50 –75 25 – 50 0–25 
Mitotic count 0–1 2–3 4–5 >5 
Type of invasion 
clearly 
demarcated 
edges 
infiltrating areas 
groups of 
infiltrating 
cells (n<15 
cells) 
widespread areas of 
dissociated cells in 
groups or as single 
cells (n>15 cells) 
Inflammation as a result of 
lymphoplasmacytic 
infiltration 
severe  moderate  insignificant no inflammation 
 
Taking into account the criteria shown in Table 1, we analysed the phases of the cell cycle of 
the studied tumours, with: 4-8 points — tumours with cells in G1 phase of the cell cycle; 9-12 points 
— G2 tumours; 13-16 points — G3 tumours. 
Assessing the level of differentiation of tumour cells, we divided patients into three groups: 
Group I — patients with tumour cells in G1 phase of mitosis (28 patients); Group II — tumour cells in 
G2 phase of mitosis (48 patients); Group III — tumour cells in the G3 phase of mitosis (54 patients). 
The mitotic activity of tumour cells was assessed by the proliferation index Ki67 and pH3, 
which we determined by immunohistochemistry. 
During the immunohistochemical study, we used paraffin blocks to prepare histological 
sections with a thickness of 4 μm, which were obtained using a rotary microtome HM 355S, Section-
Transfer-System, Walldorf. 
Upon removal of paraffin and rehydration of sections, we performed temperature unmasking 
of antigens. We performed incubation of sections with primary antibodies in humid chambers for 30 
minutes at 23-25°C, followed by staining of the test sections with hematoxylin-eosin in Ventana 
BenchMark machine (Ventana Medical Systems, Ventana, USA), and application to SuperFrost Plus 
slides. Ki67 monoclonal antibodies (monoclonal, murine anti-Ki67 antigen) were used as primary 
antibodies. We studied stained preparations on a digital light microscope Leica DM 6000 B, Leica 
Microsystems CMS GmbH using x5, x10, x20, x40, x100 lenses. 
Reaction with the pHH3 marker was performed using rabbit polyclonal antigen and was 
determined in the number of positive nuclei counted during pHH3 staining. 
We performed statistical processing of the results using the Kruskal-Wallis test to compare 
indicators in the three groups. We used Dunn’s multiple comparison test during a posteriori 
comparisons [15]. The critical level of significance was αcrit = 0.05. 
To determine the values of SUVmax, we analysed the constructed Receiver Operating 
Characteristic curves (ROC curves). We assessed the reliability of the test by the area under the ROC 
curve [15]. 
We determined the threshold for making a decision on the test by Youden index Inex=Max. 
We evaluated the prognostic characteristics of the test at the appropriate threshold by the specifics 
(95%) and sensitivity (95%) of the test. 
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We used the ROC curve method to assess the prognostic characteristics of the Ki67 and pHH3 
markers [16]. 
Results. Analysing the morphological characteristics of tumours with cells at different stages 
of the life cycle, we found significant changes between the study groups. 
The results of studies showed that at least 50% of mature cells we found in tumours with cells 
in G1 phase of the cell cycle (Group I) (Figure 1). 
 
Fig. 1. Squamous cell carcinoma of the oral cavity in G1 phase  
(hematoxylin-eosin staining, x50 magnification). 
The level of keratinization of tumour cells of squamous cell carcinoma was not less than 20%. 
Moderate-expressed (weak) polymorphism was visualized on histological sections. There was a clear 
growth of solid fields. We found a small number of cells that are in the stage of mitosis in the tumour 
tissue — from 0 to 3 cells in the field of vision. Lympho-plasmacytic infiltration is expressed by 
moderate inflammation (Figure 1). 
In the tissues of squamous cell carcinoma, the cells of which are in G2 phase of the cell cycle 
(Group II), the level of keratinization was not less than 5% (Figure 2). 
 
Fig. 2. Oral squamous cell carcinoma cells in the G2 phase  
(hematoxylin-eosin staining, x100 magnification) 
The number of mature cells was not less than 25%. Histological sections showed moderate 
polymorphism of nuclei. We established that infiltrative growth is characteristic of G2 tumours. This 
growth was expressed in the localization of small groups of cells, but there were at least 15 cells in the 
group. The sections revealed a moderate number of mitotic cells, and a slight inflammatory reaction or 
its complete absence (Figure 2). 
World Science 7(59), 2020 
 
RS Global 5 
 
The results of the study of squamous cell carcinoma in Group III patients, having the 
transformed cells in G3 phase, showed at least 25% of mature cells (Figure 3). This group includes 
tumours with a low level of keratinization and pronounced polymorphism of the nuclei. The number of 
mitotic cells was 5 or more in the field of vision. As for the G2 phase, invasive processes in the form 
of small groups of cells were observed in G3 phase. However, there were less than 15 cells in the 
group or single cells were detected in G3 tumours. Inflammation was not observed (Figure 3). 
 
Fig. 3. Oral squamous cell carcinoma cells in G2 phase  
(hematoxylin-eosin staining, x50 magnification) 
The metabolic activity of tumour cells was determined by the standardized uptake value 
(SUV) in PET [17]. 
With the help of PET diagnostics we determined both the minimum and maximum SUV in 
patients of all study groups [18]. The mean SUVmin in all patients was 5.8; the mean SUVmax was 48.7. 
Analysing the standardized uptake values — SUVmin and SUVmax depending on the degree of 
tumour differentiation revealed changes in these values in different groups of patients. Thus, in the 
group of G1 tumours the minimum value of SUVmin is 5.6, while the maximum value of SUVmax is 27. 
In Group II patients — with G2 tumours — the minimum value of SUVmin is 7, the maximum value of 
SUVmax is 28.2. In the group of G3 tumours, the minimum value of SUVmin is 5.7, the maximum value 
of SUVmax — 48.5 (Table 2). 
As the results of the study presented in Table 2 show, SUVmax increases as the cell cycle of the 
tumour cells progresses. 
 
Table 2. The value of standardized accumulation (SUV) of squamous cell carcinoma of the 
oral cavity in the Me format (QIQIII) 
Index 
Me (QI QIII) 
Significant difference 
between groups 
G1 
(n=28) 
G2 
(n=48) 
G3 
(n=54) 
SUVmax 
25.7#$ 
(18.633.3) 
28.2*$ 
(22.530.1) 
48.5*# 
(43.855.0) 
<0.001 
SUVmin 
5,6#$ 
(3.28.3) 
7,0*$ 
(4.513.1) 
5,7*# 
(3.811.0) 
<0.001 
Note:* – statistically significant difference compared with G1 tumours, p<0.05; # - statistically 
significant difference compared with G2 tumours, p<0,05; $ - statistically significant difference 
compared with G3 tumours, p <0,05. 
 
We analysed the SUVmax index in the primary tumour and determined the dependence of the 
SUVmax index on the main characteristics of the oncological process, such as the depth of invasion of 
the tumour process, histological structure, and tumour differentiation [19]. 
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The comparison of SUVmax revealed an increase in the value of this indicator with a decrease in 
the level of differentiation of tumour tissue (p<0.001 according to the Kruskal-Wallis test). The lowest 
value of SUVmax was observed in the group of patients with G1 tumours, and the highest — in patients of 
G3 group. An intermediate value of SUVmax was observed in patients with tumours with cells in G2 
phase of the life cycle. The values of this group were statistically lower than the indicators characteristic 
of G3 group, and statistically higher than the indicators characteristic of G1 group (Figure 4). 
 
Fig. 4. The value of SUVmax depending on the degree of differentiation  
of squamous cell carcinoma of the oral cavity 
Analysis of the degree of differentiation of squamous cell carcinoma of the oral cavity 
revealed a low or medium degree of differentiation of transformed cells in patients with G2 and G3 
tumours. For patients with G1 tumours, we observed a high degree of tumour cell differentiation, 
which indicates a favourable prognosis in the treatment of squamous cell carcinoma of the oral cavity. 
During the analysis of samples according to SUVmax, we revealed the adequacy of the frecasting 
model (however, AUC=0.78, which is 95%, BI is 0.70–0.85, statistically significant value, p<0.001 
exceeds 0.5). Figure 5 shows the ROC curve of the test, which indicates an important prognostic value of 
the indicator. The ROC curve of the test shows the degree of differentiation of tumour tissue (G3, G2 vs 
G1) by SUVmax, and indicates the forecasting of the tumour process [20]. Figure 5 indicates the sensitivity 
and specificity of the test, as well as the optimal decision threshold (according to Youden Index). 
 
Fig.5. ROC curve of the test for forecasting a high degree of tissue differentiation (G3, G2 vs G1) by SUVmax 
Note: the optimal decision threshold, sensitivity and specificity of the test are indicated. 
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When choosing the optimal threshold, we set a critical value of the indicator — SUVcrit, which 
equals 14. In case of exceeding this value, G2 or G3 phases of the life cycle of tumour cells are 
predicted. At this threshold, the sensitivity of the test is 71.7% (95% BI 61.8-80.3%). At the same 
time, the specificity of the test is 86.4% (95% BI 65.1-97.1%).  
In the second stage of experimental studies, we observed the degree of differentiation of 
tumour cells in patients with G3 tumours. The forecast was favourable (not the case) for patients with 
G1 or G2 tumours. 
We also revealed the adequacy of the forecasting model during the analysis of the studied 
samples according to SUVmax. However, AUC=0.70 95% CI 0.61–0.78. Figue 6 shows the ROC curve 
of the test. Its result allows asserting the importance of the quality of this indicator in the forecast of 
oncogenesis. 
 
Fig. 6. ROC curve of the test for forecasting a high degree  
of tissue differentiation (G3, G2 vs G1) by SUVmax 
Note: the optimal decision threshold, sensitivity and specificity of the test are indicated. 
When selecting the optimal threshold (according to the Youden Index), we established the critical 
value of the indicator, sensitivity and specificity. SUVcrit is 17.2. It should be noted that exceeding this 
value forecasts G3 phase of the life cycle of tumour cells. At this threshold, the sensitivity of the test is 
68.5% (95% BI 54.4-80.5%), while the specificity of the test is 70.2% (95% BI 57.7-80.7%).  
The next step was to establish a relationship between Ki67, pHH3 markers, which indicate the 
differential state of oropharyngeal carcinoma cells, and the metabolic activity of these cells, which was 
established by PET-CT in oropharyngeal squamous cell tumours. 
Correlation analysis was used to determine the relationship between Ki67 and pHH3 and SUVmax 
[21]. In this regard, the results of Spearman’s Rank correlation coefficient and the level of significance of 
its difference from 0 were expressed in the form of a correlation matrix presented in Table 3. 
 
Table 3. Correlation analysis of Ki67, pHH3 and SUVmax 
 Indicator Ki-67 pHH3 SUVmax 
Ki-67  0.814 (p<0.001) 0.214 (p=0.019) 
pHH3 0.814 (p<0.001)  0.301 (p<0.001) 
SUVmax 0.214 (p=0.019) 0.301 (p<0.001)  
 
Analysis of the results showed a strong positive correlation between the proliferation index 
(Ki67) and the mitotic count (pHH3) (r=0.814 at p<0.001). At the same time, we found a weak 
positive correlation between SUVmax and Ki-67 (r=0.214 at p=0.019) and pHH3 (r=0.301 at p<0.001). 
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As Figure 7 shows, a strong positive correlation is observed between Ki67 and pHH3. It 
follows that changes in the proliferation index of tumour cells directly depend on their mitotic activity. 
 
Fig. 7. Correlation analysis of Ki67 and pHH3 
Therefore, we found the following during the method of tracing ROC curves for the analysis 
of the prognostic characteristics of tumour cells. In the presence of 50.0% of positive cells in the test 
sample, which are determined by the level of Ki67 marker, we detected a medium or low level of 
differentiation of oropharyngeal squamous cell carcinoma. 
The pHH3 also indicates the differential state of tumour cells. Thus, 4 mitoses in the test sample, 
determined using pHH3 marker, indicates a medium and low level of differentiation of these tumours. 
An increase in the SUVmax value greater than 14 indicates an average level of differentiation of 
the studied tumours, and when the value is over 17.2 — a low level [22]. During the assessment of the 
relationship between the studied immunohistochemical markers, we established a positive correlation 
between Ki67 and pHH3 (r=0.814 at p<0.001) and a weak positive correlation between SUVmax and 
Ki67 (r=0.214) at p=0.019) and pHH3 (r=0.301 at p <0.001). 
Discussion. The obtained results indicate not only the complexity of assessing the functional 
status of cells involved in the tumour process in the oropharyngeal area, but also the importance of 
identifying key diagnostic criteria, in particular, such as metabolic activity of tumour cells. Taking into 
account these results will allow forecasting the level of differentiation of transformed squamous cell 
carcinoma in the preoperative stage, followed by the choice of effective treatment tactics. 
The dependence of SUVmax on the level of differentiation of tumour cells has also been found 
for lung cancer [23], tumours of the stomach and esophagus, lymphoma, endometrial cancer [24]. The 
results of these studies, including ours, may be the basis for creating the latest diagnostic classification 
of tumours based on the results of PET research. 
In addition, immunohistochemical markers, in particular pHH3 and Ki67 levels, make it 
possible to accurately determine the aggressiveness of tumours, regardless of individual features of the 
tumour or laboratory features of material staining. 
Conclusions. 1. In our work, we statistically proved the possibility of predicting the degree of 
differentiation of oropharyngeal carcinoma cells by the level of intake of 2-fluoro-[18F]-2-deoxy-D-
glucose by tumour tissues. The results indicate the dependence (p<0.001) of SUVmax and the level of 
differentiation of transformed cells. 2. The proliferation index Ki67 and pHH3 depend (p<0.001) on 
the number of mitotic cells in the tumour tissue and the level of histological differentiation of the 
tumour. 3. We proved that pHH3 marker can be used as a reliable criterion for assessing the level of 
tumour differentiation, which may form the basis for the diagnosis of squamous cell carcinoma. 4. We 
found a direct relationship between Ki67, pHH3 markers and the results of PET-CT in oropharyngeal 
squamous cell tumours. 
Prospects for further research. In our opinion, further study of the patterns of differentiation 
of cancer cells and their metabolic activity is a promising area for the diagnosing and screening of 
tumours of varying degrees of progression and origin, including oropharyngeal tumours. This gives 
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the prospect of their implementation in practice. An important area is also the creation of a new system 
for studying the degree of tumour differentiation depending on SUVmax, which indirectly indicates the 
level of tumour differentiation. For morphological diagnosis and detection of tumours of different 
origin, it is important to determine the proliferation potential of tumours by the number of positively 
stained cells to Ki67 (%) and pHH3 of oropharyngeal carcinoma. 
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